Table 5. Mechanisms for enabling the translation of modeled evidence for decision-making.
Government Advisory
Groups |
Consortium | Working Trainings | Formal Government
Research Partnerships |
|
---|---|---|---|---|
Definition | Government-led advisory
groups, task forces, or technical committees of experts & modelers that review available evidence & advise the government |
Partnerships between
NGOs, research/academic institutions & other stakeholders that regularly review & discuss evidence to provide guidance and advocacy to decision- makers |
Training sessions, often
organized by or with the government, that bring together researchers to develop modeling capacity through the collaborative development of a model |
Formal ad hoc partnerships,
including contractual arrangements & memoranda of understanding, established by the government with organizations that develop models to jointly explore key research questions |
Examples | Nigeria’s National Council
on Health |
• India’s SARS-CoV-2
Genome Sequencing Consortium • Nigeria’s COVID-19 Research Coalition |
• India’s Cochrane &
Campbell Collaboration trainings • India’s Center for Global Development International Decision Support Initiative |
Kenya MoH’s commission of
a report on COVID modeling efforts |
Strengths | • Allows for visibility of
available evidence • Provides space for discussion & debate • Improves transparency • Directly tied to decision- makers |
• Allows for wide visibility
of available evidence • Provides space for discussion & debate • Improves transparency |
• Develops capacity
• Encourages transparency and collaboration • Promotes government leadership in modeling |
• Intentional collaboration
• Clear expectations |
Pitfalls | May have limited
membership |
May not have direct ties to
government |
Requires organizational &
convening capacity, including funding for experts |
Certain partners may have
favored status, limiting the pool of modeling expertise & diverse perspectives |